Secondary Progressive Multiple Sclerosis Spms clinical trials

Explore recruiting secondary progressive multiple sclerosis spms clinical trials.

Recruiting secondary progressive multiple sclerosis spms studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Secondary Progressive Multiple Sclerosis Spms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-Active Secondary Progressive Multiple Sclerosis

Germany, Bulgaria, Netherlands, Sweden, Portugal, Croatia +15 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

CLASP MS: The study evaluating the efficacy and safety of Polish cladribine in the treatment of patients with secondary progressive multiple sclerosis - a phase 2, randomized, double-blind, placebo-controlled trial.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Secondary Progressive Multiple Sclerosis Spms trials by city

Secondary Progressive Multiple Sclerosis Spms in Toronto Secondary Progressive Multiple Sclerosis Spms in Vancouver Secondary Progressive Multiple Sclerosis Spms in Montreal Secondary Progressive Multiple Sclerosis Spms in Calgary Secondary Progressive Multiple Sclerosis Spms in Edmonton Secondary Progressive Multiple Sclerosis Spms in Ottawa Secondary Progressive Multiple Sclerosis Spms in Winnipeg Secondary Progressive Multiple Sclerosis Spms in Quebec City Secondary Progressive Multiple Sclerosis Spms in Hamilton Secondary Progressive Multiple Sclerosis Spms in Kitchener Secondary Progressive Multiple Sclerosis Spms in London Secondary Progressive Multiple Sclerosis Spms in Halifax Secondary Progressive Multiple Sclerosis Spms in New York Secondary Progressive Multiple Sclerosis Spms in Los Angeles Secondary Progressive Multiple Sclerosis Spms in Chicago Secondary Progressive Multiple Sclerosis Spms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease